Millennium Management’s Latigo Biotherapeutics LTGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
+83,203
New +$1.76M ﹤0.01% 4209

Other funds holding LTGO

Millennium Management's LTGO Position: Q3 2026 in Review

Millennium Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 83,203 shares worth $1.39M. The stake represents ﹤0.01% of the portfolio and ranks #4209 among its holdings.

58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.

  • Millennium Management held 83,203 shares of Latigo Biotherapeutics worth $1.39M as of Q3 2026.
  • Latigo Biotherapeutics was a new Millennium Management position in Q3 2026.
  • Latigo Biotherapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4209 holding.
  • 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.